Is H.B. Fuller Stock a Buy, Sell or Hold After the CFO Sold Shares?

Core Insights - H.B. Fuller Company CFO John Corkrean exercised stock options and sold shares, indicating a significant transaction valued at approximately $857,800 [1][2][11] Transaction Summary - John Corkrean sold 14,222 shares for about $857,800, representing 20.65% of his direct stake prior to the transaction [2][3] - After the transaction, Corkrean holds 54,646 shares valued at approximately $3.3 million [2] Company Overview - H.B. Fuller Company is a global specialty chemicals manufacturer with a revenue of $3.50 billion and a net income of $114.88 million [7][8] - The company has experienced a one-year price change of -20.34% as of October 27, 2025 [7] Financial Performance - In the fiscal third quarter ending August 30, revenue decreased by 3% year over year to $892 million [12] - The company anticipates a sales decline of 2% to 3% for the fiscal year 2025 [12] - H.B. Fuller has a net debt of nearly $2 billion, with a net debt-to-adjusted EBITDA ratio of 3.3x [12] Market Context - The shares were sold at a weighted average price of $60.31, slightly above the market close of $60.09 on the transaction date [5] - The stock's performance has been weak, with a one-year total return of -20.34% [5][11]